Tampere University, Faculty of Medicine and Health Technology

A recent study led by researchers at Tampere University investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage. The results of the new study, based on an analysis of the molecular activity of more than 10,000 genes, provide very strong evidence that the first successful drug to treat celiac disease may be at hand. 💡 https://lnkd.in/dDx3AheC

📣 Suomen Akatemian talvihaun 2024 rahoituspäätökset ovat tulleet myös LT-toimikunnan osalta: MET:lle tuli vielä yksi Akatemiahanke lisää. Lämpimät onnittelut rahoituksen saajalle!   📣 The funding decisions for the Research Council of Finland’s winter call 2024 have been announced for the NSE council: MET got one more Academy Project. Warm congratulations to the recipient!

📣 Suomen Akatemian talvihaun 2024 rahoituspäätökset ovat tulleet BTY-toimikunnan osalta! MET:ssä rahoituksen sai kaikkiaan 3 hanketta, 1 akatemiatutkija ja 2 kliinistä tutkijaa. Lämpimät onnittelut kaikille rahoituksen saaneille!   📣 The funding decisions for the Research Council of Finland’s winter call 2024 have been announced for the BHE council! At MET, a total of 3 projects, 1 Academy Research Fellow, and 2 Clinical Researchers received funding. Warm congratulations to all the recipients!

Tampereen yliopistossa vieraillut Leroy Hood esitelmöi P4-lääketieteestä (s.o pitää ihmiset terveenä pitkään ja estää sairauksien synty jo ennen niiden puhkeamista) 24.5.2024. Aamulehti julkaisi Hoodin haastattelun 3.6.2024 (Koko juttu Aamulehden tilaajille) https://lnkd.in/gsZNPvrB

Can stress be inherited? Professor Terho Lehtimäki studies the intergenerational transmission of acquired risk factors and develops tomorrow’s laboratory diagnostics. https://lnkd.in/dsknMrWt #DNA #epigenetics #research #tampereuniversity

Hypertrophic cardiomyopathy (HCM) is a cardiac disease in which several gene mutations affect its manifestation. HCM thickens heart walls and increases the risk of irregular heartbeats and sudden death. Affecting up to five in 1,000 people, it's the most common inherited cardiac disease and a leading cause of sudden death in young individuals. Despite the complexity of the disease, current approaches treat HCM as a single disease, resulting in less effective care. Enter SMASH-HCM, a €10 million EU project led by Tampere University, poised to revolutionize HCM management! SMASH-HCM develops a sophisticated digital twin – a digital replica of the heart and blood vessels, complemented by sympathetic nerve control and integrated with AI and clinical data. This advanced digital tool enhances risk assessment and enables tailored treatments for individual patients. Doctors gain improved diagnostics and can provide precise lifestyle advice. Moreover, the new tool supports healthcare, technology, and pharmaceutical industries by facilitating target discovery and cardiac safety testing. Ultimately, it promises superior treatments, outcomes, and global healthcare cost savings. 📸 Jonne Renvall / Tampere Uni #HCMawareness #DigitalHealth #PersonalizedMedicine #CardiologyInnovation #PatientCare #MedicalResearch #HealthTech #SMASHHCM

Samuli Saarni, newly appointed Professor of Psychiatry at Tampere University, studies and develops the mental health system in Finland to improve access to mental health services. ⬇ https://lnkd.in/dS_PJY3z

Tampere University is honored to receive a world-renowned scientist Dr. Leroy Hood as guest on Fri May 24th, to give a talk on a paradigm shift in #medicine. At the same event, we will hear Dr. Jennifer Lovejoy's talk on scientific #wellness. A panel discussion on a change in medicine is chaired by Dean Seppo Parkkila. The event is open for all but signing up is requested to enable organizing. Dr. Leroy Hood has, among other, developed the automated DNA sequencer that made the human genome sequence possible and 5 other instruments that laid the technical foundations of modern biology. He is also the pioneer of P4 (Predictive, Preventive, Personalised, Participatory) medicine, scientific wellness, and #systems biology, and the co-founder of the Institute for Systems Biology (ISB) in Seattle.  See link for more info on the event!. 💡 https://lnkd.in/dV863Uye

RNA has long been considered as a mere messenger that conveys genetic information from DNA to direct the synthesis of proteins in cells. In a new study led by Associate Professor (tenure track) Minna-Liisa Änkö, RNA takes the spotlight as an independent agent with the potential to transform precision cancer medicine. 🧐 https://lnkd.in/dbzZKbXi

Celiac disease is an autoimmune disease that may develop at any age. Professor Katri Lindfors delves into hereditary predispositions and immunological responses to find explanations for the onset of the disease and the diverse clinical picture. 👇 https://lnkd.in/dJUb_8uR